APA (7th ed.) Citation

HC, D., GM, G., A, H., A, S., N, K., M, B., . . . C, W. (2024). Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study. European stroke journal, 9(3), 696. https://doi.org/10.1177/23969873241242239

Chicago Style (17th ed.) Citation

HC, Diener, et al. "Efficacy and Safety of Oral Factor Xa Inhibitors Versus Vitamin-K Antagonists in the Early Phase After Acute Ischemic Stroke or TIA in the Real-world Setting: The PRODAST Study." European Stroke Journal 9, no. 3 (2024): 696. https://doi.org/10.1177/23969873241242239.

MLA (9th ed.) Citation

HC, Diener, et al. "Efficacy and Safety of Oral Factor Xa Inhibitors Versus Vitamin-K Antagonists in the Early Phase After Acute Ischemic Stroke or TIA in the Real-world Setting: The PRODAST Study." European Stroke Journal, vol. 9, no. 3, 2024, p. 696, https://doi.org/10.1177/23969873241242239.